Pulsetech Medical

Company Overview

Snapshot

Founded in January 2024 by Samer Abboud and George Tummer, Pulsetech Medical operates with 1–10 employees. The company has raised $1 million across one funding round. Pulsetech Medical is currently in the R&D product stage, focusing on developing its neuromodulation platform.

Business overview

Pulsetech Medical is a health tech and life sciences startup developing a next-generation, implantable deep brain stimulation system. This closed-loop platform is designed to continuously sense brain waves and physiological signals, apply intelligent signal processing, and adapt stimulation to each patient’s state. The technology aims to go beyond symptomatic relief to actively slow or halt the progression of serious neurological diseases, such as Parkinson’s. The company primarily serves movement-disorder neurologists and functional neurosurgeons treating advanced neurological conditions in hospital settings, operating within the medical devices and medical treatment & therapeutics sectors.

Company Intelligence Q&A

What is Pulsetech Medical's core focus?

Pulsetech Medical is developing a neuromodulation platform designed to halt the progression of neurodegenerative movement disorders, such as Parkinson's disease, using an implantable deep brain stimulation system.

When was Pulsetech Medical founded?

Pulsetech Medical was founded in January 2024.

Who are the founders of Pulsetech Medical?

The co-founders of Pulsetech Medical are Samer Abboud, who serves as CEO, and George Tummer, who is the CTO.

What is the current product stage of Pulsetech Medical?

Pulsetech Medical is currently in the R&D product stage, focusing on the development of its neuromodulation technology.

Which markets does Pulsetech Medical target?

Pulsetech Medical targets healthcare providers, specifically movement-disorder neurologists and functional neurosurgeons who treat advanced neurological conditions in hospital settings.